Tag: results
Novartis: Positive results for denosumab trial
(CercleFinance.com) – Sandoz announces further progress in its biosimilar portfolio, with the publication of positive results for the integrated Phase I/III clinical trial of denosumab. The ROSALIA study met the…
Quantum Genomics: Phase III results expected in November – 09/19/2022 at 12:18
(CercleFinance.com) – Quantum Genomics rose by more than 8% on the Paris Stock Exchange on Monday after announcing its intention to present the results of its phase III study in…
Novartis: positive results for denosumab trial
(CercleFinance.com) – Sandoz announces further progress in its biosimilar portfolio, with the publication of positive results from the integrated Phase I/III clinical trial of denosumab. The ROSALIA study met the…
QUANTUM GENOMICS: Quantum Genomics announces the presentation of the results of its phase III FRESH study, in difficult to treat/resistant hypertension, on November 4, 2022 at the annual meeting of the American Heart Association (AHA) – 09/19/2022 at 07:30
Quantum Genomics Announces Results Presentation of its phase III FRESH study, in difficult-to-treat/resistant hypertension, November 4, 2022 at the American Heart Association (AHA) Annual Meeting Quantum Genomics (Euronext Growth –…
Virbac: The results of the Virbac and Vetoquinol veterinary labs make the stock market tick
(BFM Bourse) – The rise in prices is a real challenge for the two veterinary laboratories. Inflation made its way into the half-year accounts of Virbac and Vétoquinol with various…
Wall Street opens lower, anguished by FedEx results and rising rates
The facade of the New York Stock Exchange (AFP/Angela Weiss) The New York Stock Exchange opened lower on Friday, at the end of a dark week for investors, upset by…
ACTEOS: First Half 2022 Results – 09/15/2022 at 17:35
First half of 2022: Solid business growth across all businesses and geographies 17.7% increase in turnover Results that integrate the evolution of the product mix and the investments necessary to…
Virbac saw its results improve in the first half despite inflation
PARIS (Agefi-Dow Jones)–The veterinary laboratory Virbac on Thursday confirmed most of its outlook for 2022, however reducing its debt reduction target, after recording an increase in its results in the…
REALITIES: Strong growth in 2022 half-year results – 09/15/2022 at 17:45
Strong growth in 2022 half-year results Major achievements in the 1st semester Confirmation of the turnover objective more than €400 million for 2022 • Turnover of €141.1 million: +12.6% •…
SpineGuard publishes its results for the first half of 2022 – 09/15/2022 at 18:00
To receive all of SpineGuard’s financial information in real time, send a request by email to [email protected]. • Growth in turnover of 14%• EBITDA improvement [1] by 15%• Cash horizon…
Adocia will publish its 2022 half-year results on September 19 and will hold a webinar on September 20 – 09/15/2022 at 6:00 p.m.
6 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…
Abivax presents its 2022 half-year results and provides a progress report on its activities. – 09/15/2022 at 6:05 p.m.
ABIVAX press release Abivax presents its 2022 half-year results and provides a progress report on its activities. The global pivotal Phase 3 program with obefazimod in ulcerative colitis (UC) is…